What You Need To Know
- JSUMC is participating in the Medtronic APOLLO Clinical Trial, which is evaluating the safety and efficacy of the Intrepid Transcatheter Mitral Valve Replacement System for moderate-to-severe or severe symptomatic mitral regurgitation in patients who may be unsuitable for approved transcatheter repair or surgery.
Individuals or physicians interested in more information, or for a referral to the program, should contact Dr. Saybolt and the cardiac team at 732-776-4973 or email JSUMC.StructuralHeart@hmhn.org.